Tech Company Financing Transactions
RedHill Biopharma Funding Round
Cumberland participated in a $2.5 million funding round for RedHill Biopharma. The funding round was announced on 10/22/2025.
Transaction Overview
Company Name
Announced On
10/22/2025
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
21 Ha'arba'a St
Tel Aviv, 6473921
Israel
Tel Aviv, 6473921
Israel
Phone
Website
Email Address
Overview
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/22/2025: ReproCELL venture capital transaction
Next: 10/22/2025: Scaleup Finance venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








